← All trials
NCT07063251
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 20, 2025
- Primary completion
- Feb 28, 2027
- Completion date
- Feb 28, 2028
- First posted
- Jul 14, 2025
- Last posted
- Aug 27, 2025
- Enrollment
- 6
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- HuidaGene Therapeutics Co., Ltd.Lead sponsor
- HuidaGene Therapeutics Co., Ltd.Official
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.